Logo image
Sign in
An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer
Journal article

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer

H. J. Dalton, X. Yu, L. Hu, D. S. Kapp, I. Benjamin, Bradley J. Monk and J. K. Chan
Gynecologic Oncology, Vol.124(2), pp.199-204
2012
PMID: 22055763

Metrics

4 Record Views

Details